Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

What's ahead for Apple after its rough start to 2024?

Year to date, Apple Inc. shares are down more than 10 per cent In April, Apple lost its top spot on the global smartphone list, replaced by Samsung “There are still current estimates suggesting that Apple can return 50 per cent this year&CloseCurlyDouble...

Buzz on the Bullboards: Highlights from Bay Street to Wall Street

As investors reflect on the past week’s market movements, it’s clear that some notable shifts have taken place in the Canadian and U.S. stock markets. On Bay Street, the Toronto Stock Exchange witnessed intriguing developments, while Wall S...

Buzz on the Bullboards: Pulling gains out of volatile territory

As the global economy navigates uncertainties, investors have been watching the performance of key stock markets for insights into prevailing sentiment and economic health. Over the past week, the TSX and the trio of indices on Wall Street – the Dow Jones Industrial A...

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...

Buzz on the Bullboards: Early 2024 movers in energy, tech and cannabis

The beginning of a new year always sparks hope and signals new possibilities – and that same logic can be applied to the stock market. Last year was one that traders were happy to put in the rear view. We saw high inflation, rising interest rates and a looming recessi...

Buzz on the Bullboards: Holiday blues, or blue-chips?

Are you expecting a relaxed market heading into the holidays? That will hardly be the case. Savvy investors and brokers know this is the time to shine. With every twist and turn the global economy has been throwing our way, the right move is keeping active. Th...

Buzz on the Bullboards: Cooler days means hotter markets

Autumn officially starts this weekend and with it comes the annual rush of business activity; you need look no further than our own Bullboards. Every week we track the most-viewed Bullboards stock forums in each sector and bring you some of the highlights. Some compan...

Buzz on the Bullboards: The calm before another September rally?

It’s the last leg of what looks like an end-of-month rally as investors try to make the most of August’s losses. Traders are neck-deep into a data-heavy week from company fiscal reports that could chart the hike path for interest rates. ...

Buzz on the Bullboards: Summer's most talked about stocks

August has been a rough month for North American stock markets, with red days and a lot of flat trading activity. Shares of U.S. banks fell this week after several regional lenders were hit with a credit downgrade. Retailers are stuck with products that aren&CloseCurl...

Buzz on the Bullboards: AI stocks and energy plays getting noticed

Markets have had it rough, starting the month of August lower following one downer of a corporate earnings report after another. Wall Street has struggled since credit assessor Fitch downgraded the United States’ credit rating from gold-standard AAA to...
1 2 3 4 5 6 7 8 9 10 ...